Asia-Pacific markets poised to open lower after Wall Street staged a comeback

Asia-Pacific markets poised to open lower after Wall Street staged a comeback


SINGAPORE — Futures in the Asia-Pacific pointed to a lower open in the region despite Wall Street recovering most of its losses by the close.

The Nikkei futures contract in Chicago was at 26,240 while its counterpart in Osaka was at 26,220. That compared against the Nikkei 225’s last close at 26,423.47.

In Australia, SPI futures were at 6,477, lower than the S&P/ASX 200’s last close at 6,629.3.

Stock picks and investing trends from CNBC Pro:

U.S. stock indexes initially fell sharply on Tuesday stateside before rallying in the afternoon. The Nasdaq Composite ended the session 1.75% higher at 11,322.24, while the S&P 500 was up 0.16% at 3,831.39,

The Dow Jones Industrial Average shed 129.44 points, or 0.4%.

In central bank news, Bank Negara Malaysia is expected to release its monetary policy statement today. Analysts polled by Reuters expect the bank to raise rates by 25 basis points.

Currencies and oil

The U.S. dollar index, which tracks the greenback against a basket of its peers, was last at 106.535, jumping from below 105.3.

The Japanese yen traded at 135.5 per dollar, strengthening from more than 136 against the greenback on Tuesday. The Australian dollar weakened to $0.6795 against the stronger U.S. dollar.

“The deteriorating global economy is the main weight on AUD,” Kristina Clifton, an economist at Commonwealth Bank of Australia wrote in a note Wednesday.

In Asia’ morning trade, West Texas Intermediate crude was up 1.5% at $100.99.

The U.S. oil benchmark plunged as much as 10%, breaking the $100 level on Tuesday stateside before settling 8.24% lower at $99.50 on the back of recession fears.

International benchmark Brent crude settled 9.45%, or $10.73, lower at $102.77 per barrel.



Source

Ozempic maker Novo Nordisk lowers growth outlook for its weight loss drugs as pricing pressures mount
World

Ozempic maker Novo Nordisk lowers growth outlook for its weight loss drugs as pricing pressures mount

A box of Ozempic sits on a table in North Tyneside, Britain, Oct. 31, 2023. Lee Smith | Reuters Danish pharmaceutical giant Novo Nordisk said Wednesday it is trimming its growth expectations for its leading obesity and diabetes treatments as competition intensifies and pricing pressures mount in the weight loss market. Net profit for the […]

Read More
Europe to open lower as markets question tech valuations; Novo Nordisk earnings ahead
World

Europe to open lower as markets question tech valuations; Novo Nordisk earnings ahead

European stocks are expected to open lower, mirroring global declines as concerns grow over sky-high tech valuations. Source

Read More
California voters approve new U.S. House map to boost Democrats in 2026
World

California voters approve new U.S. House map to boost Democrats in 2026

California voters approved new congressional district boundaries Tuesday, delivering a victory for Democrats in the state-by-state redistricting battle that will help determine which party wins control of the U.S. House in 2026 and, with it, the power to thwart or advance President Donald Trump’s agenda. The approval of Proposition 50 gives Democrats a shot at […]

Read More